SAREPTA THERAPEUTICS INC revenue breakdown overview

SAREPTA THERAPEUTICS INC revenue for the last year amounted to 1.84 B EUR, the most of which — 1.73 B EUR — came from its highest performing source at the moment, RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities, the year earlier bringing 1.04 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought SAREPTA THERAPEUTICS INC 1.58 B EUR, and the year before that — 904.47 M EUR.